Skip to content
Cpi-1205
Cpi-1205 is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against histone-lysine N-methyltransferase EZH2.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
3 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C6111———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C801————1
B-cell lymphomaD0163931————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCPI-1205
INNlirametostat
Description
Cpi-1205 is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against histone-lysine N-methyltransferase EZH2.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1cc(C)[nH]c(=O)c1CNC(=O)c1c(C)n([C@H](C)C2CCN(CC(F)(F)F)CC2)c2ccccc12
Identifiers
PDB—
CAS-ID1450656-11-7
RxCUI—
ChEMBL IDCHEMBL4297463
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID455J2479FY (ChemIDplus, GSRS)
Target
Agency Approved
EZH2
EZH2
Organism
Homo sapiens
Gene name
EZH2
Gene synonyms
KMT6
NCBI Gene ID
2146
Protein name
histone-lysine N-methyltransferase EZH2
Protein synonyms
Enhancer of zeste homolog 2, ENX-1, Lysine N-methyltransferase 6
Uniprot ID
Q96FI6
Mouse ortholog
Ezh2 (14056)
histone-lysine N-methyltransferase EZH2 (Q9R090)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 18 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1 adverse events reported
View more details